Jump Financial »

Crinetics Pharmaceuticals In shares owned by Jump Financial

Quarter-by-quarter ownership of Crinetics Pharmaceuticals In (CRNX) shares owned by Jump Financial from 13F filings

Historical chart of Jump Financial investment in Crinetics Pharmaceuticals In

Tip: Access up to 7 years of quarterly data

All positions including Crinetics Pharmaceuticals In held by Jump Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crinetics Pharmaceuticals In by Jump Financial

Quarter filed Position value Share count Share price at filing
2023-12-31 $964k 27k 35.58
2023-09-30 $1.4M 48k 29.74
2022-09-30 $560k 29k 19.65

More positions owned by Jump Financial

Invesco Qqq Tr Etf (QQQ)
Ishares Tr Etf (IWM)
Spdr S&p 500 Etf Tr Etf (SPY)
Vanguard Index Fds Etf (VOO)
Ishares Tr Etf (TLT)
Proshares Tr Etf (SQQQ)
Ishares Tr Etf (IVV)
Proshares Tr Etf (PSQ)
Microsoft Corp Common Stock (MSFT)
Spdr Ser Tr Etf (SPLG)
Nvidia Corporation Common Stock (NVDA)
Proshares Tr Etf (SSO)
Amazon Common Stock (AMZN)
Proshares Tr Etf (TQQQ)
Direxion Shs Etf Tr Etf (SPXL)

View all positions for Jump Financial

Top funds holding Crinetics Pharmaceuticals In

Vanguard Group
Point72 Asset Management
Wellington Management Company
T. Rowe Price Associates
Jennison Associates
Paradigm Biocapital Advisors
EcoR1 Capital
First Light Asset Management
OrbiMed Advisors
Perceptive Advisors
Cormorant Asset Management
Eventide Asset Management
Ikarian Capital
Lord, Abbett & Co
Dimensional Fund Advisors

View all funds holding Crinetics Pharmaceuticals In